Haemonetics Corp. (HAE)
108.39
-0.41
(-0.38%)
USD |
NYSE |
Aug 24, 16:00
108.39
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Profit Margin (Quarterly) : 9.73% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.73% |
| March 31, 2026 | -5.82% |
| December 31, 2025 | 13.20% |
| September 30, 2025 | 11.82% |
| June 30, 2025 | 10.59% |
| March 31, 2025 | 17.54% |
| December 31, 2024 | 10.76% |
| September 30, 2024 | 9.79% |
| June 30, 2024 | 11.41% |
| March 31, 2024 | 5.93% |
| December 31, 2023 | 9.29% |
| September 30, 2023 | 7.83% |
| June 30, 2023 | 13.18% |
| March 31, 2023 | 9.65% |
| December 31, 2022 | 10.79% |
| September 30, 2022 | 11.16% |
| June 30, 2022 | 7.60% |
| March 31, 2022 | 3.68% |
| December 31, 2021 | 8.94% |
| September 30, 2021 | 6.19% |
| June 30, 2021 | -1.95% |
| March 31, 2021 | -4.91% |
| December 31, 2020 | 13.26% |
| September 30, 2020 | 22.96% |
| June 30, 2020 | 5.38% |
| Date | Value |
|---|---|
| March 31, 2020 | 7.39% |
| December 31, 2019 | 11.54% |
| September 30, 2019 | 14.84% |
| June 30, 2019 | -3.56% |
| March 31, 2019 | 8.36% |
| December 31, 2018 | 7.39% |
| September 30, 2018 | 7.75% |
| June 30, 2018 | -1.23% |
| March 31, 2018 | 5.09% |
| December 31, 2017 | -2.80% |
| September 30, 2017 | 8.92% |
| June 30, 2017 | 9.55% |
| March 31, 2017 | -22.42% |
| December 31, 2016 | 6.76% |
| September 30, 2016 | 9.00% |
| June 30, 2016 | -4.93% |
| March 31, 2016 | -3.61% |
| December 31, 2015 | -25.47% |
| September 30, 2015 | 5.86% |
| June 30, 2015 | -0.13% |
| March 31, 2015 | -1.29% |
| December 31, 2014 | 6.90% |
| September 30, 2014 | 3.29% |
| June 30, 2014 | -1.63% |
| March 31, 2014 | 4.22% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp. | 16.63% |
| Integra LifeSciences Holdings Corp. | 1.07% |
| Globus Medical, Inc. | 19.20% |
| Abbott Laboratories | 7.37% |
| AngioDynamics, Inc. | -13.17% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 11.26% |
| Return on Assets | 3.96% |
| Return on Invested Capital | 4.63% |
| Gross Profit Margin (Quarterly) | 56.98% |
| Operating Margin (Quarterly) | 17.61% |
| Return on Net Operating Assets | 5.05% |